drugset / Trial / NCT02561091
AM-111 in the Treatment of Acute Inner Ear Hearing Loss
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this research study is to test the effectiveness and safety of the study drug, AM-111. AM-111 is tested for the treatment of sudden sensorineural hearing loss where the cause is unknown.
Timeline
- Start
- 2015-11
- Primary completion
- 2017-09
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BRIMAPITIDE, C-TERMINAL ACID | Protein / enzyme biologic | 0.4 mg/ml | Other |
| Subject | BRIMAPITIDE, C-TERMINAL ACID | Protein / enzyme biologic | 0.8 mg/ml | Other |